# US 2015/0105548 A1 · Anti-viral compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105548 A1
- Document ID: US20150105548A1
- Status: Published application
- Kind: A1
- Application number: 14/365,611
- Filed: 2012-05-25
- Published: 2015-04-16
- Earliest claimed: 2011-05-26
- Applicants: Abbvie Inc
- Inventors: Allan Krueger; Warren M. Kati; Clarence J. Maring; Rolf Wagner; Charles W. Hutchins
- Web page: https://patentgrep.com/patent/US20150105548A1

## CPC

- C07D 513/04: Ortho-condensed systems
- A61P 31/12: Antivirals
- C07D 471/04: Ortho-condensed systems
- C07D 487/04: Ortho-condensed systems
- C07D 498/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to anti-HCV compounds, compositions comprising the same and methods of using the same to treat HCV infection.

## Claims

### Claim 1

A compound of Formula (1-I) or pharmaceutically acceptable salts thereof:
or a pharmaceutically acceptable salt thereof, wherein:
A and B are each independently absent or selected from the group consisting of O, optionally substituted C1-C4 alkyl, optionally substituted C2-C4 alkenyl, and optionally substituted C2-C4 alkynyl, and A or B is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as defined below;
Ring M is a monocyclic or polycyclic group independently selected from the group consisting of aryl, heteroaryl, heterocyclic, C3-C8 cycloalkyl, and C3-C8 cycloalkenyl, each optionally substituted; wherein ring M is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as defined below;
Ring G and Ring J are each independently an optionally substituted 5- or 5/6-fused membered heteroaryl; wherein the 5-membered heteroaryl contains one or more nitrogen, and wherein the 6-membered ring of said 5/6-fused membered heteroaryl is attached to one of A, B, and Ring M, and is aryl or heteroaryl; wherein at least one of Ring G or Ring J is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as defined below;
W is selected from
Q is selected from
Y is CH or C(C1-C4 alkyl);
T is N, CH or C(C1-C4 alkyl);
E at each occurrence is absent or independently selected from the group consisting of O, S, S(O), SO2, NC(O)—(C1-C4 alkyl), C(O), protected carbonyl, OCH2, OCH2CH2, SCH2, SCH2CH2, C(R7)2, and C(R7)2, C(R7)2; preferably E is optionally substituted CH2;
R7 at each occurrence is independently selected from the group consisting of hydrogen, halogen, cyano, hydroxy, O(C1-C4 alkyl), S(C1-C4 alkyl), amino optionally substituted with one or two C1-C4 alkyl, optionally substituted aryl, optionally substituted heteroaryl, and optionally substituted C1-C4 alkyl; preferably hydrogen, halogen or hydroxy;
R3 and R4 are each independently selected from the group consisting of hydrogen, optionally substituted C1-C8 alkyl, optionally substituted C2-C8 alkenyl, and optionally substituted C3-C8 cycloalkyl; preferably hydrogen or optionally substituted C1-C4 alkyl; alternatively, R3 and R4 are taken together with the carbon atom to which they are attached to form optionally substituted C3-C8 cycloalkyl or optionally substituted heterocyclic;
R5 is independently hydrogen, optionally substituted C1-C8 alkyl, or optionally substituted C3-C8 cycloalkyl; preferably hydrogen or optionally substituted C1-C4 alkyl;
R6 at each occurrence is independently selected from the group consisting of optionally substituted O(C1-C8 alkyl), optionally substituted amino, —NR11NRaRb and —R12;
R11 at each occurrence is independently selected from the group consisting of hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, heterocyclic, aryl, and heteroaryl, each optionally substituted;
Ra is hydrogen or optionally substituted C1-C8 alkyl;
Rb is —C(O)—R13, —C(O)—OR13, —S(O)2—R13, —C(O)N(R13)2, or —S(O)2N(R13)2;
R13 at each occurrence is selected from the group consisting of C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, heterocyclic, aryl, and heteroaryl, each optionally substituted; or Ra and Rb can be taken together with the nitrogen atom to which they are attached to form an optionally substituted heterocyclic or optionally substituted heteroaryl group;
R12 at each occurrence is selected from the group consisting of hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, heterocyclic, aryl, and heteroaryl, each optionally substituted; preferably optionally substituted C1-C8 alkyl; also preferably C1-C8 alkyl optionally substituted with amino, hydroxy, protected amino or O(C1-C4 alkyl); and
R7a and R7b at each occurrence are each independently selected from the group consisting of hydrogen, optionally substituted aryl, and optionally substituted —C1-C4 alkyl; or alternatively, CHR7a-E or CHR7b-E can be taken together to form a group selected from CH═CH, optionally substituted C3-C8 cycloalkyl, optionally substituted aryl, or optionally substituted heterocyclic; or yet alternatively, E, R7a, and R7b can be taken together with the carbon atoms to which they are attached to form a bridged 5- to 7-membered ring,
L is -LS-, -LS-O-LS′-, -LS-C(O)-LS′-, -LS-S(O)2-LS′-, -LS-S(O)-LS′-, -LS-OS(O)2-LS′-, -LS-S(O)2O-LS′-, -LS-OS(O)-LS′-, -LS-S(O)O-LS′-, -LS-C(O)O-LS′-, -LS-OC(O)-LS′-, -LS-OC(O)O-LS′-, -LS-C(O)N(RB)-LS′-, -LS-N(RB)C(O)-LS′-, -LS-C(O)N(RB)O-LS′-, -LS-N(RB)C(O)O-LS′-, -LS-OC(O)N(RB)-LS′-, -LS-C(O)N(RB)N(RB′)-LS′-, -LS-S-LS′-, -LS-C(S)-LS′-, -LS-C(S)O-LS′-, -LS-OC(S)-LS′-, -LS-C(S)N(RB)-LS′-, -LS-N(RB)-LS′-, -LS-N(RB)C(S)-LS′-, -LS-N(RB)S(O)-LS′-, -LS-N(RB)S(O)2-LS′-, -LS-S(O)2N(RB)-LS′-, -LS-S(O)N(RB)-LS′-, -LS-C(S)N(RB)O-LS′-, -LS-C(O)N(RB)C(O)-LS′-, -LS-N(RB)C(O)N(RB′)-LS′-, -LS-N(RB)SO2N(RB′)-LS′-, -LS-N(RB)S(O)N(RB′)-LS′-, or -LS-C(S)N(RB)N(RB′)-LS′-;
LS and LS′ are each independently selected at each occurrence from bond; or C1-C6alkylene, C2-C6 alkenylene or C2-C6 alkynylene, each of which is independently optionally substituted at each occurrence with one or more RL;
RA is independently selected at each occurrence from halogen, oxo, thioxo, hydroxy, mercapto, nitro, cyano, amino, carboxy, formyl, phosphonoxy, or phosphono; or -LS-RE;
RB and RB′ are each independently selected at each occurrence from hydrogen; or C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C3-C6 carbocycle or 3- to 6-membered heterocycle; or C3-C6 carbocycle or 3- to 6-membered heterocycle; wherein each C3-C6 carbocycle or 3- to 6-membered heterocycle in RB or RB′ is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl or C2-C6 haloalkynyl;
RE is independently selected at each occurrence from —O—RS, —S—RS, —C(O)RS, —OC(O)RS, —C(O)ORS, —N(RSRS′), —S(O)RS, —SO2RS, —C(O)N(RSRS′), —N(RS)C(O)RS′, —N(RS)C(O)N(RS′RS″), —N(RS)SO2RS′, —SO2N(RSRS′), —N(RS)SO2N(RS′RS″), —N(RS)S(O)N(RS′RS″), —OS(O)—RS, —OS(O)2—RS, —S(O)2ORS, —S(O)ORS, —OC(O)ORS, —N(RS)C(O)ORS′, —OC(O)N(RSRS′), —N(RS)S(O)—RS′, —S(O)N(RSRS′) or —C(O)N(RS)C(O)—RS′; or C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl or cyano; or C3-C6carbocycle or 3- to 6-membered heterocycle, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl or C2-C6 haloalkynyl;
RL is independently selected at each occurrence from halogen, nitro, oxo, phosphonoxy, phosphono, thioxo, cyano, —O—RS, —S—RS, —C(O)RS, —OC(O)RS, —C(O)ORS, —N(RSRS′), —S(O)RS, —SO2RS, —C(O)N(RSRS′) or —N(RS)C(O)RS′; or C3-C6 carbocycle 3- to 6-membered heterocycle, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl or C2-C6 haloalkynyl;
RS, RS′ and RS″ are each independently selected at each occurrence from hydrogen; C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano or 3- to 6-membered carbocycle or heterocycle; or 3- to 6-membered carbocycle or heterocycle; wherein each 3- to 6-membered carbocycle or heterocycle in RS, RS′ or RS′ is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C3-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl or C2-C6 haloalkynyl;
L3 is bond or -LS-K-LS′-, wherein K is selected from bond, —O—, —S—, —N(RB)—, —C(O)—, —S(O)2—, —S(O)—, —OS(O)—, —OS(O)2—, —S(O)2O—, —S(O)O—, —C(O)O—, —OC(O)—, —OC(O)O—, —C(O)N(RB)—, —N(RB)C(O)—, —N(RB)C(O)O—, —OC(O)N(RB)—, —N(RB)S(O)—, —N(RB)S(O)2—, —S(O)N(RB)—, —S(O)2N(RB)—, —C(O)N(RB)C(O)—, —N(RB)C(O)N(RB′)—, —N(RB)SO2N(RB′)—, or —N(RB)S(O)N(RB′)—;
D is C3-C12 carbocycle or 3- to 12-membered heterocycle, and is optionally substituted with one or more RA; or D is C3-C12 carbocycle or 3- to 12-membered heterocycle which is substituted with J and optionally substituted with one or more RA, where J is C3-C12 carbocycle or 3- to 12-membered heterocycle and is optionally substituted with one or more RA, or J is —SF5; or D is hydrogen or RA;
RA is independently selected at each occurrence from halogen, nitro, oxo, phosphonoxy, phosphono, thioxo, cyano, or -LS-RE, wherein two adjacent RA, taken together with the atoms to which they are attached and any atoms between the atoms to which they are attached, can optionally form carbocycle or heterocycle;
RB and RB′ are each independently selected at each occurrence from hydrogen; or C1-C6alkyl, C2-C6 alkenyl or C2-C6 alkynyl, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano or 3- to 6-membered carbocycle or heterocycle; or 3- to 6-membered carbocycle or heterocycle; wherein each 3- to 6-membered carbocycle or heterocycle in RB or RB′ is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C6haloalkyl, C2-C6haloalkenyl or C2-C6haloalkynyl;
RE is independently selected at each occurrence from —O—RS, —S—RS, —C(O)RS, —OC(O)RS, —C(O)ORS, —N(RSRS′), —S(O)RS, —SO2RS, —C(O)N(RSRS′), —N(RS)C(O)RS′, —N(RS)C(O)N(RS′RS″), —N(RS)SO2RS′, —SO2N(RSRS′), —N(RS)SO2N(RS′RS″), —N(RS)S(O)N(RS′RS″), —OS(O)—RS, —OS(O)2—RS, —S(O)2ORS, —S(O)ORS, —OC(O)ORS, —N(RS)C(O)ORS′, —OC(O)N(RSRS′), —N(RS)S(O)—RS′, —S(O)N(RSRS′), —P(O)(ORS)2, or —C(O)N(RS)C(O)—RS′; or C1-C6alkyl, C2-C6 alkenyl or C2-C6 alkynyl, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl or cyano; or C3-C6 carbocycle or 3- to 6-membered heterocycle, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C(O)ORS, or —N(RSRS′);
RL is independently selected at each occurrence from halogen, nitro, oxo, phosphonoxy, phosphono, thioxo, cyano, —O—RS, —S—RS, —C(O)RS, —OC(O)RS, —C(O)ORS, —N(RSRS′), —S(O)RS, —SO2RS, —C(O)N(RSRS′) or —N(RS)C(O)RS′; or C3-C6 carbocycle 3- to 6-membered heterocycle, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl or C2-C6 haloalkynyl; wherein two adjacent RL, taken together with the atoms to which they are attached and any atoms between the atoms to which they are attached, can optionally form carbocycle or heterocycle;
LS and LS′ are each independently selected at each occurrence from bond; or C1-C6alkylene, C2-C6alkenylene or C2-C6alkynylene, each of which is independently optionally substituted at each occurrence with one or more RL; and
RS, RS′ and RS″ are each independently selected at each occurrence from hydrogen; C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, each of which is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, —O—C1-C6alkyl, —O—C1-C6 alkylene-O—C1-C6 alkyl, or 3- to 6-membered carbocycle or heterocycle; or 3- to 6-membered carbocycle or heterocycle; wherein each 3- to 6-membered carbocycle or heterocycle in RS, RS′ or RS′ is independently optionally substituted at each occurrence with one or more substituents selected from halogen, hydroxy, mercapto, amino, carboxy, nitro, oxo, phosphonoxy, phosphono, thioxo, formyl, cyano, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 haloalkyl, C2-C6 haloalkenyl or C2-C6 haloalkynyl.

### Claim 2 (depends on 1)

A compound of Formula (2-I) or pharmaceutically acceptable salts thereof:
or a pharmaceutically acceptable salt thereof, wherein:
A and B are each independently absent or selected from the group consisting of O, optionally substituted C1-C4 alkyl, optionally substituted C2-C4 alkenyl, and optionally substituted C2-C4 alkynyl, and A or B is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as defined below;
Ring M is a monocyclic or polycyclic group independently selected from the group consisting of aryl, heteroaryl, heterocyclic, C3-C8 cycloalkyl, and C3-C8 cycloalkenyl, each optionally substituted, wherein ring M is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as defined in claim 1;
Ring G and Ring J are each independently an optionally substituted 5- or 5/6-fused membered heteroaryl; wherein the 5-membered heteroaryl contains one or more nitrogen, and wherein the 6-membered ring of said 5/6-fused membered heteroaryl is attached to one of A, B and Ring M, and is aryl or heteroaryl; wherein at least one of Ring G or Ring J is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as in claim 1;
W is selected from
R1 at each occurrence is independently hydrogen or optionally substituted C1-C4 alkyl, wherein R1 is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as defined as in claim 1;
R2 at each occurrence is independently hydrogen, optionally substituted C1-C8 alkyl, or —NRaRb, R2 is preferably is substituted with -L-E or preferably -L3-D, wherein -L-E or -L3-D are as defined as in claim 1;
Ra at each occurrence is independently hydrogen or optionally substituted C1-C8 alkyl;
Rb at each occurrence is independently —C(O)—R13, —C(O)—OR13, —S(O)2—R13, —C(O)N(R13)2, or —S(O)2N(R13)2;
or alternatively, Ra and Rb can be taken together with the nitrogen atom to which they are attached to form an optionally substituted heterocyclic or optionally substituted heteroaryl group;
R13 at each occurrence is independently selected from the group consisting of C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, heterocyclic, aryl, and heteroaryl, each optionally substituted;
E at each occurrence is independently O, S, OC(R1)2, SC(R1)2, OC(R1)2C(R1)2, or SC(R1)2C(R1)2;
X at each occurrence is independently absent, CH2 or CH2CH2;
Y at each occurrence is independently absent or C(R1)2, C(R1)2C(R7)2, C(R1)2C(R7)2C(R7)2, C(R1)2OC(R1)2, or C(R1)2SC(R1)2;
R7 at each occurrence is independently selected from the group consisting of hydrogen, halogen, cyano, hydroxy, O(C1-C4 alkyl), S(C1-C4 alkyl), amino optionally substituted with one or two C1-C4 alkyl, optionally substituted aryl, optionally substituted heteroaryl, and optionally substituted C1-C4 alkyl; preferably hydrogen, halogen or hydroxy;
wherein when W is
at least one of X and Y is present;
T at each occurrence is independently CH or C(C1-C4 alkyl); or alternatively, when Y is present, T-Y can be taken together to form C═CR1, C═CR1—CH2, or C═CR1—CH2CH2;
Q is selected from:
wherein when Q is
at least one of X and Y is present;
U is absent or selected from the group consisting of O, S, S(O), SO2, NC(O)—(C1-C4 alkyl), C(O), protected carbonyl, OCH2, OCH2CH2, SCH2, SCH2CH2, C(R7)2, and C(R7)2C(R7)2; preferably C(R7)2;
R3 and R4 are each independently selected from the group consisting of hydrogen, optionally substituted C1-C8 alkyl, optionally substituted C2-C8 alkenyl, and optionally substituted C3-C8 cycloalkyl; preferably hydrogen or optionally substituted C1-C4 alkyl; or alternatively, R3 and R4 can be taken together with the carbon atom to which they are attached to form optionally substituted C3-C8 cycloalkyl or optionally substituted heterocyclic;
R5 is hydrogen, optionally substituted C1-C8 alkyl, or optionally substituted C3-C8 cycloalkyl; preferably hydrogen or optionally substituted C1-C4 alkyl;
R6 is selected from the group consisting of optionally substituted O(C1-C8 alkyl), optionally substituted amino, —NR11NRaRb or R12;
R11 is selected from the group consisting of hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, heterocyclic, aryl, and heteroaryl, each optionally substituted;
R12 at each occurrence is independently selected from the group consisting of hydrogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, heterocyclic, aryl, and heteroaryl, each optionally substituted; preferably optionally substituted C1-C8 alkyl; also preferably C1-C8 alkyl optionally substituted with amino, hydroxy, protected amino or O(C1-C4 alkyl); and
R7a and R7b at each occurrence are each independently selected from the group consisting of hydrogen, optionally substituted aryl, and optionally substituted C1-C4 alkyl; or alternatively, CHR7a—U or CHR7b—U can be taken together to form a group selected from CH═CH, optionally substituted C3-C8 cycloalkyl, optionally substituted aryl, or optionally substituted heterocyclic; or yet alternatively, U, R7a, and R7b can be taken together with the carbon atoms to which they are attached to form a bridged 5- to 7-membered ring.
